论文信息 - A new feature of the MYH9‐related syndrome: Chronic transaminase elevation

A new feature of the MYH9‐related syndrome: Chronic transaminase elevation

1. Zhang JX, Li DQ, He AR, Motwani M, Vasiliou V, Eswaran J, et al. Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases. HEPATOLOGY 2012;55:1840-1851. 2. Ma NF, Hu L, Fung JM, Xie D, Zheng BJ, Chen L, et al. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. HEPATOLOGY 2008;47:503-510. 3. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 2009;325:1240-1243. 4. Gottschalk AJ, Timinszky G, Kong SE, Jin J, Cai Y, Swanson SK, et al. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc Natl Acad Sci U S A 2009; 106:13770-13774. 5. Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 2009;27:5459-5468.

[1] V. Vasiliou,et al. Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP‐ribose) polymerases , 2012, Hepatology.

[2] P. Noris,et al. Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome , 2012, PloS one.

[3] A. Savoia,et al. Recent advances in the understanding and management of MYH9‐related inherited thrombocytopenias , 2011, British journal of haematology.

[4] J. Timmermans,et al. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells. , 2011, Journal of hepatology.

[5] B. Freedman,et al. The spectrum of MYH9-associated nephropathy. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[6] A. Savoia,et al. Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains. , 2004, Genomics.

[7] U Magrini,et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. , 2000, Nature genetics.